We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DakoCytomation Acquires Artisan Line from CytoLogix

By HospiMedica staff writers
Posted on 18 Sep 2002
In a move to expand the company's range of diagnostic instruments, DakoCytomation A/S (Copenhagen, Denmark) has acquired the Artisan instrument business from CytoLogix Corp. (Cambridge, MA, USA). Financial details were not disclosed.

Artisan is a tissue staining instrument used in pathology laboratories for cancer diagnosis. Under the terms of the agreement, DakoCytomation will assume all rights to the product as well as responsibility for continued technical support and service. DakoCytomation US will retain the CytoLogix facility in Cambridge, which will be used for ongoing product development and for customer training and support. DakoCytomation is an in vitro diagnostics company specializing in the identification of cancer markers on samples obtained from tissue and body fluids.

"The addition of CytoLogix' Artisan product line will considerably strengthen our core business, as it gives us a broader platform within our leadership position in cancer diagnostics,” said Jes Ostergaard, president and CEO of DakoCytomation.





Related Links:
DakoCytomation
CytoLogix

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Centrifuge
Centrifuge 5430/ 5430 R
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests